Read full paper at: http://www.scirp.org/journal/PaperInformation.aspx?PaperID=51257#.VGAe6mfHRK0 Author(s) Jungyeob Seoung , Young-Han Park * , Chaechun Rhim , Sungju Kim Affiliation(s) Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Hallym University Sacred Heart Hospital, Anyang, South Korea . ABSTRACT Ovarian cancer is the most aggressive gynecologic cancer of the heterogenous phenotypes. Development of the new chemotherapeutic agents and drug delivery mode makes better outcomes for patient treatments. Optimal cytoreductive therapy followed by molecular targeting therapy, intraperitoneal chemotherapy and dose dense chemotherapy is a hot therapeutic concept in ovarian cancers. I...
Scientific Research Publishing